Forodesine

DRUG2 trials

Sponsors

Mundipharma Research Limited

Conditions

B-cell Chronic Lymphocytic LeukemiaB-cell Precursor Acute Lymphoblastic LeukaemiaRelapsed or Refractory T-cell Acute Lymphoblastic LeukaemiaT-cell Non-Hodgkin's Lymphoma

Phase 1

Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia

TerminatedNCT00646165

Mundipharma Research LimitedB-cell Chronic Lymphocytic Leukemia

Start: 2008-07-31End: 2009-05-31Updated: 2010-03-31

Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.

TerminatedNCT00742495

Mundipharma Research LimitedB-cell Precursor Acute Lymphoblastic Leukaemia, Relapsed or Refractory T-cell Acute Lymphoblastic Leukaemia, T-cell Non-Hodgkin's Lymphoma

Start: 2009-03-31End: 2010-09-30Updated: 2012-10-24